HIW
ABBV icon

Holos Integrated Wealth’s AbbVie ABBV Stock Holding History

Holos Integrated Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Hold
904
– – 0.11% 76
2026
Q1 		$187K Hold
904
– – 0.09% 92
2025
Q4 		$207K Buy
904
+73
+9% +$16.6K 0.12% 68
2025
Q3 		$191K Hold
831
– – 0.11% 66
2025
Q2 		$164K Sell
831
-72
-8% -$13.4K 0.1% 70
2025
Q1 		$189K Hold
903
– – 0.12% 67
2024
Q4 		$161K Buy
+903
New +$166K 0.11% 60

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Holos Integrated Wealth's ABBV Position: Q2 2026 in Review

Holos Integrated Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 904 shares worth $230K. The position accounts for 0.11% of the portfolio, ranked #76.

Holos Integrated Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Holos Integrated Wealth held 904 shares of AbbVie worth $230K as of Q2 2026.
  • Holos Integrated Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.11% of Holos Integrated Wealth's portfolio in Q2 2026, its #76 holding.
  • Holos Integrated Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Holos Integrated Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.